Stryker Stock Market Value
| SYK Stock | USD 369.53 5.87 1.61% |
| Symbol | Stryker |
Stryker Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.53) | Dividend Share 3.24 | Earnings Share 7.76 | Revenue Per Share | Quarterly Revenue Growth 0.107 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Stryker 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Stryker's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Stryker.
| 12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Stryker on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Stryker or generate 0.0% return on investment in Stryker over 90 days. Stryker is related to or competes with Boston Scientific, Abbott Laboratories, Medtronic PLC, DexCom, Edwards Lifesciences, Zimmer Biomet, and ZimVie. Stryker Corporation operates as a medical technology company More
Stryker Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Stryker's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Stryker upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0371 | |||
| Maximum Drawdown | 6.96 | |||
| Value At Risk | (1.71) | |||
| Potential Upside | 2.25 |
Stryker Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stryker's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Stryker's standard deviation. In reality, there are many statistical measures that can use Stryker historical prices to predict the future Stryker's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | 0.0079 | |||
| Total Risk Alpha | 0.1047 | |||
| Treynor Ratio | (0.1) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Stryker's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Stryker Backtested Returns
Stryker owns Efficiency Ratio (i.e., Sharpe Ratio) of close to zero, which indicates the firm had a close to zero % return per unit of risk over the last 3 months. Stryker exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Stryker's Risk Adjusted Performance of (0.03), variance of 1.73, and Coefficient Of Variation of (2,624) to confirm the risk estimate we provide. The entity has a beta of 0.62, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Stryker's returns are expected to increase less than the market. However, during the bear market, the loss of holding Stryker is expected to be smaller as well. At this point, Stryker has a negative expected return of -0.0014%. Please make sure to validate Stryker's maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Stryker performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.56 |
Good reverse predictability
Stryker has good reverse predictability. Overlapping area represents the amount of predictability between Stryker time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Stryker price movement. The serial correlation of -0.56 indicates that roughly 56.0% of current Stryker price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.56 | |
| Spearman Rank Test | -0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 82.78 |
Stryker lagged returns against current returns
Autocorrelation, which is Stryker stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Stryker's stock expected returns. We can calculate the autocorrelation of Stryker returns to help us make a trade decision. For example, suppose you find that Stryker has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Stryker regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Stryker stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Stryker stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Stryker stock over time.
Current vs Lagged Prices |
| Timeline |
Stryker Lagged Returns
When evaluating Stryker's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Stryker stock have on its future price. Stryker autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Stryker autocorrelation shows the relationship between Stryker stock current value and its past values and can show if there is a momentum factor associated with investing in Stryker.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Stryker Correlation, Stryker Volatility and Stryker Alpha and Beta module to complement your research on Stryker. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Stryker technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.